Clinitech Laboratory IPO opens on July 25, 2024, and closes on July 29, 2024. The allotment for the Clinitech Laboratory IPO is anticipated to be completed on Tuesday, July 30, 2024. The IPO will be listed on the BSE and SME, with a tentative date of Wednesday, August 1,2024.
The price band for the Clinitech Laboratory IPO is set at Rs 96 per share. The IPO is a book-built issue of Rs 5.78 crores, entirely a fresh issue of 6.02 Lakhs shares.
Clinitech Laboratory IPO Details
| IPO Date | July 25, 2024 to July 29, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹96 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 602,400 shares (aggregating up to ₹5.78 Cr) |
| Fresh Issue | 602,400 shares (aggregating up to ₹5.78 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding pre-issue | 1,680,000 |
| Shareholding post-issue | 2,282,400 |
| Market Maker portion | 31,200 shares |
Clinitech Laboratory IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 1200 | ₹115,200 |
| Retail (Max) | 1 | 1200 | ₹115,200 |
| HNI (Min) | 2 | 2400 | ₹230,400 |
Clinitech Laboratory IPO Objectives
The objectives of the Issue are:
- Expansion of Diagnostic Centres; and
- General Corporate Purpose.
About Clinitech Laboratory Limited
Founded in 1990, Clinitech Laboratory Limited operates as a diagnostic and healthcare services provider with a network of eight diagnostic centers located in and around Thane and Navi Mumbai. The company offers over 150 different tests and conducts more than three lakh tests annually. Clinitech Laboratory’s facilities are equipped with modern technology and high-quality equipment, ensuring accurate and reliable results. The company’s commitment to quality is reflected in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation.
The medical testing facilities at Clinitech Laboratory’s Airoli, Navi Mumbai center have been accredited by NABL as per ISO 15189:2012. This accreditation underscores the laboratory’s adherence to international standards in medical testing, ensuring the highest levels of accuracy and reliability in their diagnostic services. Clinitech Laboratory continues to uphold its reputation for excellence in the healthcare industry, providing essential diagnostic services to the community.
Clinitech Laboratory Limited Financial Information
Clinitech Laboratory Limited’s revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 560.79 | 603.33 | 368.74 | 273.32 |
| Revenue | 643.92 | 636.34 | 645.70 | 459.63 |
| Profit After Tax | 37.12 | 61.31 | 51.26 | 40.24 |
| Net Worth | 354.80 | 238.08 | 184.81 | 139.03 |
| Reserves and Surplus | 186.80 | 88.08 | 34.81 | 72.37 |
| Total Borrowing | 86.31 | 102.91 | 88.61 | 53.67 |
Clinitech Laboratory IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Retail Shares Offered | 50% of the Net Issue |
| Other Shares Offered | 50% of the Net Issue |
Clinitech Laboratory IPO Timeline
Clinitech Laboratory IPO opens on July 25, 2024, and closes on July 29, 2024.
| IPO Open Date | Thursday, July 25, 2024 |
| IPO Close Date | Monday, July 29, 2024 |
| Basis of Allotment | Tuesday, July 30, 2024 |
| Initiation of Refunds | Wednesday, July 31, 2024 |
| A credit of Shares to Demat | Wednesday, July 31, 2024 |
| Listing Date | Thursday, August 1, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 29, 2024 |
Conclusion
Clinitech Laboratory Limited, a prominent diagnostic and healthcare services provider established in 1990, is launching its IPO from July 25 to July 29, 2024, with shares priced at Rs 96 each. The IPO, a fixed price issue, aims to raise Rs 5.78 crores through a fresh issue of 602,400 shares. The proceeds will fund the expansion of diagnostic centers and general corporate purposes. Clinitech, accredited by NABL, operates eight centers in Thane and Navi Mumbai, offering over 150 tests annually. Despite a revenue increase, their profit after tax saw a significant drop in the latest fiscal year. The shares will be listed on the BSE SME on August 1, 2024.
